It seems our philosophies about treatments are very similar. When I was first diagnosed at age 58, I realized the risks of treatment were about even with the risks of the disease. I was very careful to educate myself before accepting any of them. I was also adamantly opposed to parting with my spleen. The success rate in my age group is less than 40%.
I went mostly untreated for the first three years or so. Then, single-digit counts started to occur more frequently, so I began taking a daily dose of prednisone, never going above 20 mgs. After two more years, that regimen lost its dependability, but I refused to raise the dose. My doctor then encouraged me to try Rituxan. I was initially very reluctant, being concerned from reading personal accounts here on the board of patients who'd acquired serum sickness from the treatment. After several months, I agreed to it. While the office nurse set about getting insurance approval for it, a kind of primal fear kicked up in my gut. I felt that I would be harmed and ultimately backed out. By that time, NPlate had been in use for more than 10 years and had FDA approval for ITP, which are my personal benchmarks for trying any new kind of med. In October of 2014, I started NPlate but couldn't achieve a stable count of 50 that is the goal of TPO treatment.
When I finally had enough of wildly fluctuating counts with NPlate in 2018, I decided to set aside my fear, trust my doctor, and go ahead with Rituxan. Sure enough, I was felled by serum sickness and spent six days in the hospital, two of them in ICU. I was left with permanent vestibular nerve damage that causes me disability every single day and will never improve. No professional will admit that Rituxan caused this problem for me, but I'm a good researcher. I found journal articles that describe the same kind of vestibular damage caused by a monoclonal AB drug for an AI disease.
So now I'm about to turn 73 and am still taking NPlate. I've thought many times about switching to Promacta to see if it would produce more stable counts. But it would cost me at least $80 a month, while NPlate costs me nothing under my Medicare advantage plan. Besides, I found a small study that concluded there's little chance that a switch from one to the other would achieve a better result. I may someday decide to investigate the newest drugs available now that work by different mechanisms than the TPOs. But for now, I'm satisfied with counts that run between 30 and 100. My lowest count in the last four years was 20, and I haven't had a single-digit count in that time.
Yes, I know I have a higher risk of a clot when my count is above 50, but I choose to accept it. At 73, I'd have a similar risk of clots WITHOUT taking NPlate, at least as I see it. Sorry this turned out so long, but it's my story. Hope it helps, at least a little.